Beijing Aosaikang Pharmaceutical Co.,Ltd. Posted 220 Million Yuan Net Loss in First Three Quarters of 2023

Beijing Aosaikang Pharmaceutical Co.,Ltd. (北京奥赛康药业股份有限公司) (002755.SZ) reported a net loss of 220 million yuan in the first three quarters of 2023, widening 129.5% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 25.7% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 598.8 million yuan in total liabilities, with a liability-to-asset ratio of 17.4%.